Fig. 7

Immune landscape in low- and high-risk groups. A The number of mutations and neoantigens in low- and high-risk group patients. B The immune exclusion score, T cell dysfunction score, TIDE score, and MSI score in low- and high-risk groups. C ROC curves of TIDE score and risk. D TMB in low- and high-risk groups. E KM curves between high TMB and low TMB. F KM curves combined TMB and risk score. G Immune score, stromal score, and ESTIMATE score in low- and high-risk group. H Expression of immune checkpoint inhibitors in high- and low-risk groups. I Calculation of immune cell infiltration by MCP algorithm. J Difference of IPS with CTLA4- and PD-1-, CTLA4- and PD-1 + , CTLA4 + , and PD-1 and CTLA4 + and PD-1 + . K The result of GSVE between low- and high-risk. L ssGSEA results